KM Financial Solutions | UPDATE 2-Minnesota sues opioid manufacturer Insys over drug marketing
18461
post-template-default,single,single-post,postid-18461,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 2-Minnesota sues opioid manufacturer Insys over drug marketing

UPDATE 2-Minnesota sues opioid manufacturer Insys over drug marketing

May 30 (Reuters) – Minnesota on Wednesday became the latest
state to sue Insys Therapeutics Inc, accusing the
drugmaker of illegally marketing a powerful fentanyl-based pain
medicine intended for cancer patients for other uses and
improperly paying doctors to prescribe it.

No Comments

Sorry, the comment form is closed at this time.